fromNews Center
1 month ago'Dancing Molecules' Treatment Receives FDA Orphan Drug Designation - News Center
"Dancing molecules," the promising new treatment for acute spinal cord injuries developed at Northwestern University, has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA).
Science